Haleon HLN
NYSE HLN
$9.91 +0.05 (+0.46%)
At close: Aug 20, 2026 · 12:02 PM UTC

Haleon (HLN) Profit After Tax Growth (3y) (2025)

Haleon (HLN) Profit After Tax Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Haleon 44.05 Bn 43.08 Bn - -
2 Teva Pharmaceutical Industries 43.39 Bn 39.74 Bn 2.15 Bn 14.01%
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn -0.23%
4 Takeda Pharmaceutical 28.78 Bn 22.99 Bn 5.10 Bn 2.89%
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn 8.71%
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn -34.81%
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn 15.37%
8 Elanco Animal Health 11.92 Bn 11.39 Bn 798.00 Mn 36.74%
9 Dr Reddys Laboratories 10.16 Bn 9.99 Bn - -
10 Alkermes 8.17 Bn 7.51 Bn 397.90 Mn -87.17%

Historic Data

Download Data
DateValue
Dec 31, 2025 0.72%